(Q44961359)

English

Comparison of long-term effects of lymphoblastoid interferon alpha and recombinant interferon alpha-2a therapy in patients with chronic hepatitis B.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Comparison of long-term effects of lymphoblastoid interferon alpha and recombinant interferon alpha-2a therapy in patients with chronic hepatitis B. (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

S-M Lin

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

D-I Tai

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

R-N Chien

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

I-S Sheen

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

C-M Chu

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Y-F Liaw

6

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

publication date

1 July 2004

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

349-357

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Treatment of hepatocellular carcinoma with recombinant leucocyte interferon: a pilot study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00512.X

21 January 2018

Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00512.X

21 January 2018

Breakthrough during recombinant interferon alfa therapy in patients with chronic hepatitis C virus infection: prevalence, etiology, and management

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00512.X

21 January 2018

Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus: a pilot study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00512.X

21 January 2018

Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00512.X

21 January 2018

Cost-effectiveness of interferon-alpha 2b treatment for hepatitis B e antigen-positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00512.X

21 January 2018

Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00512.X

21 January 2018

Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00512.X

21 January 2018

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00512.X

21 January 2018

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00512.X

21 January 2018

Hepatitis B e antigen and the risk of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00512.X

21 January 2018

A controlled trial of interferon with or without prednisone priming for chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00512.X

21 January 2018

Identifiers

10.1111/J.1365-2893.2004.00512.X

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44961359&oldid=1694396318"